Halozyme Therapeutics Inc. (HALO)

$ 68.41
   
  • Change Today:
    $0.05
  • 52 Week High: $78.28
  • 52 Week Low: $47.74
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 428,164
  • Market Cap: $9,940m
  • RiskGrade: 189

HALO Overview

1 Day Chart (24-12-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,342.35 816.29 627.40¢ 10.9 n/a n/a n/a 0.0%
31-Dec-26 1,675.93 1,089.16 813.00¢ 8.4 0.3 +30% n/a 0.0%
31-Dec-27 1,887.98 1,296.54 955.50¢ 7.2 0.4 +18% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 68.41
Change Today $ 0.05
% Change 0.07 %
52 Week High $78.28
52 Week Low $47.74
Volume 428,164
Shares Issued 145.30m
Market Cap $9,940m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page